المؤلفون: Susan Keam

مصطلحات موضوعية: Medicine, Momelotinib, Adis Insight Report, Adis Drug Review, First Approval, myelofibrosis, JAK1/JAK2 inhibitor, ACVR1 inhibitor, post-essential thrombocythemia, activin A receptor type I inhibitor

Relation: https://figshare.com/articles/online_resource/Momelotinib_First_Approval/24431317

الاتاحة: https://doi.org/10.6084/m9.figshare.24431317.v1
https://figshare.com/articles/online_resource/Momelotinib_First_Approval/24431317

المؤلفون: Xin Cui, Junming Du, Zongqing Jia, Xilong Wang, Haiyong Jia

المصدر: BMC Chemistry, Vol 13, Iss 1, Pp 1-7 (2019)

مصطلحات موضوعية: Baricitinib, JAK1/JAK2 inhibitor, Green synthesis, Microchannel reactor, Chemistry, QD1-999

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s13065-019-0639-y; https://doaj.org/toc/2661-801X

URL الوصول: https://doaj.org/article/28d8fe359bb44685b4c485a6aae9313f

المساهمون: Chul Won Jung, Lee Yung Shih, Koichi Akashi, Prashanth Gopalakrishna, Kazuo Ito, Taro Amagasaki, Yu Hu, Ting Liu, Katsuto Takenaka, Wu Depei, Ming Hou, Kohshi Ohishi, Li Jianyong, Hiroshi Handa, Junmin Li, Shigeki Saito, Daobin Zhou, Jin Seok Kim, Tetsuzo Tauchi, Shinichiro Okamoto, Kenji Oritani, Ki Seong Eom, Seonyang Park, Ming Chung Wang, Xin Du, Hsin An Hou, Jin Jie, Zhijian Xiao, Kim, Jin Seok

مصطلحات موضوعية: Adult, Aged, 80 and over, Asian Continental Ancestry Group, Female, Follow-Up Studies, Humans, Janus Kinase 1/antagonists & inhibitors, Janus Kinase 2/antagonists & inhibitors, Male, Middle Aged, Neoplasm Staging, Primary Myelofibrosis/drug therapy, Primary Myelofibrosis/pathology, Prognosis, Protein Kinase Inhibitors/therapeutic use, Pyrazoles/therapeutic use, Quality of Life, Asian patient population, JAK1/JAK2 inhibitor, Myelofibrosis, phase 2

Relation: LEUKEMIA & LYMPHOMA; J02165; OAK-2014-03414; https://ir.ymlib.yonsei.ac.kr/handle/22282913/139147; T201506182; LEUKEMIA & LYMPHOMA, Vol.56(7) : 2067-2074, 2015

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/139147
https://doi.org/10.3109/10428194.2014.969260
http://www.tandfonline.com/doi/full/10.3109/10428194.2014.969260

المؤلفون: Tiziano Barbui, Xiaolei Zhou, Ruben A. Mesa, Deborah S. Hunter, Jean-Jacques Kiladjian, Richard S. Levy, Giovanni Barosi, Alessandro M. Vannucchi, Margaret Squier, Catherine Copley-Merriman, Francesco Passamonti, Laurent Knoops, Claire N. Harrison, Francisco Cervantes, Haifa Kathrin Al-Ali, Estella Mendelson, Heinz Gisslinger, Andres Sirulnik

المصدر: British Journal of Haematology. 162:229-239

مصطلحات موضوعية: Male, Ruxolitinib, Pediatrics, medicine.medical_specialty, Health-related quality of life, Myelofibrosis, JAK1/JAK2 inhibitor, Quality of life, Weight loss, Surveys and Questionnaires, Nitriles, medicine, Humans, In patient, Protein Kinase Inhibitors, Aged, business.industry, Cancer, Janus Kinase 1, Hematology, Janus Kinase 2, medicine.disease, humanities, Lymphoma, Pyrimidines, Treatment Outcome, Primary Myelofibrosis, Quality of Life, Pyrazoles, Itching, Female, medicine.symptom, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e870a5b6f31c1dc701bb107b68f828
https://doi.org/10.1111/bjh.12375

المؤلفون: Harrison, C. N., Mesa, R. A., Kiladjian, J. J., Al Ali, H. K., Gisslinger, H., Knoops, L., Squier, M., Sirulnik, A., Mendelson, E., Zhou, X., Copley Merriman, C., Hunter, D. S., Levy, R. S., Cervantes, F., Barbui, T., Barosi, G., Vannucchi, A. M., PASSAMONTI, FRANCESCO

المساهمون: Harrison, C. N., Mesa, R. A., Kiladjian, J. J., Al Ali, H. K., Gisslinger, H., Knoops, L., Squier, M., Sirulnik, A., Mendelson, E., Zhou, X., Copley Merriman, C., Hunter, D. S., Levy, R. S., Cervantes, F., Passamonti, Francesco, Barbui, T., Barosi, G., Vannucchi, A. M.

مصطلحات موضوعية: Health-related quality of life, JAK1/JAK2 inhibitor, Myelofibrosi, Ruxolitinib, socio, envir

Relation: http://hdl.handle.net/11383/2023346

الاتاحة: http://hdl.handle.net/11383/2023346